NYSE News: NYSE 100, NYSE 250, and NYSE 400 investment news
NYSE market news from the New York Stock Exchange

Latest NYSE News:

  • Oil, solar sectors gain on record crude prices

  • Microsoft up 9.2 percent on quarterly results

  • New home sales numbers don’t help Wall Street

  • Dow loses over 130 points by midday

  • Merck profits up 62 percent in third quarter

  • Quarterly reports disappoint Wall Street

  • Wall Street lower on banking sector

  • Wall Street mixed to end session

  • Home builders decline on comments, news

  • Citigroup lower on quarterly report

  • NYSE news feed


    Recommended equities news sites

  • NYSE
  • NasDaq
  • Dow Jones
  • Finance & Money
  • Eurofirst News
  • Tokyo Market News
  • FTSE News
  •  

    September 19, 2006

    ImClone down after court ruling

    Filed under: Centex, Toll Brothers, Administaff, Google, Yahoo, Dow Jones, ImClone Systems

    Wall Street was lower by the middle of the session on Tuesday after new data showed that new housing starts were down sharply in August and Yahoo issued a profits warning. By midday, the Dow Jones Industrial Average was 0.5 percent lower to 11,502.09, while the Nasdaq Composite had dropped 1.1 percent to 2,212.25 and the S&P 500 was 0.5 percent lower to 1,315.23.

    The news that housing starts were down by 6 percent in August, double the expected drop, hurt the homebuilding sector. Centex and Toll Brothers each dropped 3.2 percent to $51.94 and $27.27 respectively.

    Internet search engine Yahoo was 11.6 percent lower to $25.65 when its chief financial officer announced that this quarters results would only reach the lower levels of earlier predictions. The news also hurt Google, which fell 4.5 percent to $395.77.

    Dow Jones, which publishes the Wall Street Journal, was also lower on a revised earnings guidance, dropping 2.5 percent to $33.02. In yet another lowered guidance, semiconductors company Maxim Integrated Products declined by 6.1 percent to $29.45.

    In the pharmaceuticals sector, ImClone Systems fell 6.3 percent to $28.59 after a judged ruled that the process it used to come up with its cancer drug Erbitux was actually invented by three Israeli scientists, whose employer could be entitled to royalties due to ImClone’s use of the process.





    Latest Equities News:

  • Wall Street ends lower despite rate cut

  • Asia-Pacific, Europe equities see declines

  • Hang Seng adds 10.72 percent on session

  • India’s Sensex drops 1,408 points on session

  • Australian markets drop for 9th straight day

  • Taiex gains on opposition win in parliamentary elections

  • Hang Seng drops nearly 400 points

  • Most Asia-Pacific markets drop on US recession worries

  • Tokyo declines on export worries

  • Asia-Pacific equities mixed on economic concerns

  • NYSE News copyright 2005 Central Consultants